LENZ Therapeutics, Inc.
LENZ · NASDAQ
Bulios Fair Price
$5.03
32.7% upside
Trenutna cena
$3.79
Po podatkih Bulios Fair Price je delnica LENZ trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
LENZ Therapeutics (LENZ) is a biotechnology company based in the United States, focused on developing new therapeutic treatments for neurological disorders, particularly epilepsy and other central nervous system disorders. The company specializes in discovering and developing innovative drugs aimed at improving the lives of patients suffering from these serious diseases. LENZ Therapeutics utilizes advanced technologies and scientific insights to discover new therapeutic possibilities and focuses on the efficacy and safety of its products. LENZ Therapeutics (LENZ) shares could be suitable for investors looking to invest in the biotechnology sector with potential for innovations in the treatment of neurological disorders.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Evert Schimmelpennink
Employees
152
Headquarters
Solana Beach
Prihajajoči dogodki
Earnings
Upcoming earnings report